secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIFECORE BIOMEDICAL, INC. DE (LFCR)
CIK:        0001005286
Form:       8-K
Filed at:   2023-01-11T23:59:59+00:00
Accession:  0001005286-23-000027
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifecore Biomedical receives Nasdaq notice for delayed Q2 FY2023 10-Q filing
----------------------------------------------------------------------------

- Nasdaq notified Lifecore on Jan 11, 2023 of non-compliance with Listing Rule 5250(c)(1) due to late 10-Q.
- Company has 60 days (until Mar 12, 2023) to submit a plan to regain compliance.
- If plan accepted, Nasdaq may grant up to 180 days from original due date (until Jul 5, 2023) to file.
- No immediate impact on listing or trading of common stock on Nasdaq Global Select Market.
- Lifecore states it is working diligently to complete and file the 10-Q as promptly as possible.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1005286/000100528623000027/0001005286-23-000027-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1005286/000100528623000027/lndc-20230111.htm
  HTML page:      https://secwatch.observer/filing/0001005286-23-000027

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer